Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: HDT BIO CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-01 to 2021-11-30
Current total value of award: $599629
Description: EO14042 - RATIONAL DEVELOPMENT OF A COMBINATION NANOPARTICLE ADJUVANT FOR INFLUENZA.